Salvage surgery for advanced non–small cell lung cancer after response to gefitinib
T Hishida, K Nagai, T Mitsudomi, K Yokoi… - The Journal of Thoracic …, 2010 - jtcvs.org
Salvage surgery for advanced non–small cell lung cancer after response to gefitinib - The
Journal of Thoracic and Cardiovascular Surgery Skip to Main Content Advertisement The …
Journal of Thoracic and Cardiovascular Surgery Skip to Main Content Advertisement The …
Salvage surgery for a super-responder by gefitinib therapy for advanced lung cancer
K Hashimoto, H Horinouchi, T Ohtsuka… - General thoracic and …, 2012 - Springer
Salvage surgery after gefitinib therapy in a 66-year-old female with cT4N1M1a lung
adenocarcinoma in the right middle lobe, which had gene mutation of epidermal growth …
adenocarcinoma in the right middle lobe, which had gene mutation of epidermal growth …
Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review
Y Yamamoto, K Kodama, T Maniwa… - Journal of Cardiothoracic …, 2017 - Springer
Background The usefulness of residual tumor resection after epidermal growth factor
receptor tyrosine kinase inhibitor (EGFR-TKI) treatment remains unclear. We describe two …
receptor tyrosine kinase inhibitor (EGFR-TKI) treatment remains unclear. We describe two …
Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases
T Hishida, J Yoshida, K Aokage, K Nagai… - General thoracic and …, 2016 - Springer
We report the long-term outcome of 4 patients who underwent pulmonary resection for
residual or regrown primary lesion of non-small cell lung cancer (NSCLC) treated with a …
residual or regrown primary lesion of non-small cell lung cancer (NSCLC) treated with a …
Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy
M Liu, G Jiang, W He, P Zhang, N Song - The Annals of Thoracic Surgery, 2011 - Elsevier
First-line therapy with gefitinib prolongs progression-free survival and improves quality of life
among selected patients with non-small cell lung cancer. Selected locally advanced patients …
among selected patients with non-small cell lung cancer. Selected locally advanced patients …
Effect of gefitinib on the survival of patients with recurrence of lung adenocarcinoma after surgery: a retrospective case-matching cohort study
BACKGROUND: Patients with lung adenocarcinoma who carry epidermal growth factor
receptor (EGFR) gene mutations respond remarkably well to EGFR tyrosine kinase inhibitor …
receptor (EGFR) gene mutations respond remarkably well to EGFR tyrosine kinase inhibitor …
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenaka, M Takenoyama… - European Journal of …, 2015 - academic.oup.com
OBJECTIVES The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
[HTML][HTML] Gefitinib versus placebo in completely resected non–small-cell lung cancer: results of the NCIC CTG BR19 study
GD Goss, C O'Callaghan, I Lorimer… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Purpose Survival of patients with completely resected non–small-cell lung cancer (NSCLC)
is unsatisfactory, and in 2002, the benefit of adjuvant chemotherapy was not established …
is unsatisfactory, and in 2002, the benefit of adjuvant chemotherapy was not established …
[HTML][HTML] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie, G Jiang - Annals of translational …, 2018 - ncbi.nlm.nih.gov
Background This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
Pneumonectomy after response to gefitinib treatment for lung adenocarcinoma
Y Funakoshi, Y Takeuchi… - … and Thoracic Annals, 2013 - journals.sagepub.com
A 69-year-old Japanese woman who had never smoked had lung adenocarcinoma
harboring epidermal growth factor receptor mutation. After 8 months of gefitinib treatment …
harboring epidermal growth factor receptor mutation. After 8 months of gefitinib treatment …